2023 Annual Meeting | C47 - Clinical Pearls in Autoimmune Neurology: Real-world Cases
01:00 PM - 01:05 PM EST | Introduction |
Session Aims and Outline
Sarosh R. Irani, MD, PhD, FRCP, FEAN |
01:05 PM - 01:35 PM EST | Speaker |
Case-based Pearls and Errors in Diagnosing Demyelinating Conditions - MS, MOGAD, NMOSD and More
Brian G. Weinshenker, MD, FAAN |
01:35 PM - 01:45 PM EST | Q&A |
Questions and Answers
Brian G. Weinshenker, MD, FAAN |
01:45 PM - 02:10 PM EST | Speaker |
Case-based Pearls and Errors in Diagnosing Autoimmune Encephalitis and Related Syndromes
Sarosh R. Irani, MD, PhD, FRCP, FEAN |
02:10 PM - 02:20 PM EST | Q&A |
Questions and Answers
Sarosh R. Irani, MD, PhD, FRCP, FEAN |
02:20 PM - 02:45 PM EST | Speaker |
Case-based Pearls and Errors in Diagnosing Emerging Autoimmune Peripheral Nerve and Muscle Conditions
Divyanshu Dubey, MD, FAAN |
02:45 PM - 02:55 PM EST | Q&A |
Questions and Answers
Divyanshu Dubey, MD, FAAN |
02:55 PM - 03:00 PM EST | Closing Remarks |
Review of Aims and Closing Remarks
Sarosh R. Irani, MD, PhD, FRCP, FEAN |
Brian G. Weinshenker, MD, FAAN | Dr. Weinshenker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CANbridge Pharmaceuticals. Dr. Weinshenker has received personal compensation in the range of $0-$499 for serving as a Consultant for CALIBR. Dr. Weinshenker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Group (Chugai, Genentech, Roche). Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharmaceuticals. Dr. Weinshenker has received research support from Guthy Jackson Charitable Foundation. Dr. Weinshenker has received intellectual property interests from a discovery or technology relating to health care. |
Sarosh R. Irani, MD, PhD, FRCP, FEAN | Dr. Irani has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for UCB, Immunovant, MedImmun, Roche, Janssen, Cerebral therapeutics, Biogen, Amgen, Argenex, Clarivate, IQVIA, BioHaven therapeutics, ADC therapeutics, Brain, CSL Behring, and ONO Pharma.. Dr. Irani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Irani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Irani has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain. Dr. Irani has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for LLPs. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. |
Divyanshu Dubey, MD, FAAN | The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from UCB. Dr. Dubey has received research support from David J. Tomassoni ALS Research Grant Program . Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. |